Zachary Wells, DO
Adult Reconstructive Orthopaedic Surgery · Palm Harbor, FLNPI 1558866657
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.3%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Smith+Nephew at 37.6% of the total. Reporting peaked in 2024 at $6,260 and has fallen 89.5% since, to $658 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in FL, where the typical reported total is $11,822.
Across 99 payments — averaging $134.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Stryker$4K
- Ortho Development Corporation$2K
- Zimmer Biomet$1K
- Sanara Medtech Inc.$411
- Omnilife Science, Inc$370
- plus $912 from 12 others
What the payments were for
- Grants$2,50019%
- Travel & lodging$3,50326%
- Food & beverage$4,85036%
- Education$2,50019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $5,015 |
| Stryker | 60 | $3,959 |
| Ortho Development Corporation | 5 | $1,606 |
| Zimmer Biomet | 8 | $1,080 |
| Sanara Medtech Inc. | 3 | $411 |
| Omnilife Science, Inc | 3 | $370 |
| Biocomposites Inc | 1 | $153 |
| Acumed LLC | 4 | $153 |
| Linkbio Corp | 1 | $137 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Medical Device Business Services, Inc. | 3 | $106 |
| Solventum Corporation | 1 | $99 |
| Polynovo North America LLC | 1 | $48 |
| Coastal Medical Technologies LLC | 1 | $27 |
| Medtronic | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,379
- Arcos$662
- CellerateRx$386
- T2 ALPHA$286
- Various Products$272
- Trivicta$172
- TRIATHLON$171
- Stimulan$153
- GAMMA$146
- TAPESTRY$134
- AXSOS$126
- Zynrelef$125
- FIXOS$121
- CAPRI CORPECTOMY CAGE SYSTEM$119
How this compares
$13,353 in reported general payments places this provider in the 50th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 43 | $232 |
| Tramadol Hcl | 49 | $184 |
| Meloxicam | 68 | $152 |
| Ondansetron Hcl | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Palm Harbor
- Christopher JamesPalm Harbor$12K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.